Geron Corporation (GERN) Social Stream



Geron Corporation (GERN): $3.27

-0.05 (-1.51%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add GERN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#373 of 378

in industry

GERON CORP (GERN) Price Targets From Analysts

Use the tables below to see what analysts covering GERON CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-11 3 $7 $3 $4.5 $3.14 43.31%
2022-05-10 4 $7 $3 $4.5 $3.14 43.31%
2022-07-11 4 $7 $3 $4.666 $3.14 48.6%
2022-08-12 5 $7 $3 $4.2 $3.14 33.76%
2022-10-27 6 $7 $3 $4.285 $3.14 36.46%
2022-10-28 6 $7 $3 $4.333 $3.14 37.99%
2022-12-13 5 $7 $3 $4.333 $3.14 37.99%
2023-01-04 5 $7 $3 $4.5 $3.14 43.31%
2023-01-08 5 $7 $3 $4.8 $3.14 52.87%
2023-01-09 5 $7 $3 $5.2 $3.14 65.61%
2023-03-17 4 $6 $4 $5 $3.14 59.24%
2023-05-12 5 $6 $3 $4.6 $3.14 46.5%

The Trend in the Analyst Price Target


GERN's average price target has moved up $0.1 over the prior 18 months.

Over the past 44 weeks, GERN's average upside potential has been 94.94%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-07-11 3 7 3 4.666 1.77 163.62%
2022-08-12 5 7 3 4.250 2.35 80.85%
2023-01-04 5 7 3 4.500 3.19 41.07%
2023-01-09 5 7 3 5.200 2.95 76.27%
2023-05-12 5 6 3 4.600 3.10 48.39%

GERN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.6 3 1 1 0 0 5

The Trend in the Broker Recommendations


Over the past 19 months, GERN's average broker recommendation rating improved by 0.2.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how GERON CORP fares relative to all US stocks, note that its average analyst price target is higher than 54.98% of that group.
  • In the context of all US stocks, GERON CORP's variance in analysts' estimates is lower than -1176.25% of them.
  • GERON CORP's number of analysts covering the stock is greater than 421.91% of Healthcare stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, GERON CORP's upside potential (average analyst target price relative to current price) is greater than 449.82% of them.

In the Pharmaceutical Products industry, VERU, IMGN, and LFVN are the three stocks most similar to GERON CORP regarding the price target and analyst recommendation information presented here.

Is GERN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9614 seconds.